CollPlant Biotechnologies (CLGN) Receivables - Net (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Receivables - Net of $1000.0 for Q4 2025, down 100.0% on a QoQ basis from $150.0 million in Q4 2024, and down 100.0% year-over-year from $150.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Receivables - Net (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Receivables - Net history runs 9 years deep, the most recent figure standing at $1000.0 for Q4 2025.
- Quarterly Receivables - Net fell 100.0% year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 100.0% YoY) and the FY2025 annual result came in at $1000.0, down 100.0% from the prior year.
- Receivables - Net was $1000.0 for Q4 2025 at CollPlant Biotechnologies, down from $150.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $270.0 billion in Q4 2021 and bottomed at $1000.0 in Q4 2025.
- A 5-year average of $18.0 billion and a median of $4.0 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net surged 32530020.48% — and 2025, when it plunged 100.0%.
- CollPlant Biotechnologies' Receivables - Net stood at $270.0 billion in 2021, then plunged by 100.0% to $9.0 million in 2022, then plunged by 55.56% to $4.0 million in 2023, then surged by 3650.0% to $150.0 million in 2024, then plunged by 100.0% to $1000.0 in 2025.
- Business Quant data shows CLGN's Receivables - Net at $1000.0 in Q4 2025, $150.0 million in Q4 2024, and $5.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 150.00 Mn |
| Dec 31, 2024 | 150.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90.00 Mn |
| Mar 31, 2024 | 90.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 323,000.00 |
| Mar 31, 2023 | 323,000.00 |
| Dec 31, 2022 | 9.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |